These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 32822127)
41. Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer. Choi YH; Yu JW; Kang MY; Sung HH; Jeong BC; Seo SI; Jeon SS; Lee HM; Jeon HG World J Urol; 2019 Oct; 37(10):2129-2135. PubMed ID: 30603783 [TBL] [Abstract][Full Text] [Related]
42. Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Crouzet S; Chapelon JY; Rouvière O; Mege-Lechevallier F; Colombel M; Tonoli-Catez H; Martin X; Gelet A Eur Urol; 2014 May; 65(5):907-14. PubMed ID: 23669165 [TBL] [Abstract][Full Text] [Related]
43. Results of high intensity focused ultrasound treatment of prostate cancer: early Canadian experience at a single center. Elterman DS; Barkin J; Radomski SB; Fleshner NE; Liu B; Bensimon K; Arora S; Robinette M; Finelli A Can J Urol; 2011 Dec; 18(6):6037-42. PubMed ID: 22166332 [TBL] [Abstract][Full Text] [Related]
44. Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project. Scheltema MJ; Tay KJ; Postema AW; de Bruin DM; Feller J; Futterer JJ; George AK; Gupta RT; Kahmann F; Kastner C; Laguna MP; Natarajan S; Rais-Bahrami S; Rastinehad AR; de Reijke TM; Salomon G; Stone N; van Velthoven R; Villani R; Villers A; Walz J; Polascik TJ; de la Rosette JJMCH World J Urol; 2017 May; 35(5):695-701. PubMed ID: 27637908 [TBL] [Abstract][Full Text] [Related]
45. "In-bore" MRI prostate biopsy is a safe preoperative clinical tool to exclude significant prostate cancer in symptomatic patients with benign prostatic obstruction before transurethral laser enucleation. Porreca A; D'Agostino D; Vigo M; Corsi P; Romagnoli D; Del Rosso A; Schiavina R; Brunocilla E; Artibani W; Giampaoli M Arch Ital Urol Androl; 2020 Jan; 91(4):224-229. PubMed ID: 31937084 [TBL] [Abstract][Full Text] [Related]
46. Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experience. Fugaru I; Bouhadana D; Marcq G; Moryousef J; Rompré-Brodeur A; Meng A; Loutochin O; Loutochin G; Anidjar M; Bladou F; Sanchez-Salas R Can J Urol; 2024 Feb; 31(1):11784-11792. PubMed ID: 38401258 [TBL] [Abstract][Full Text] [Related]
47. Real-Time MRI-Guided Focused Ultrasound for Focal Therapy of Locally Confined Low-Risk Prostate Cancer: Feasibility and Preliminary Outcomes. Ghai S; Louis AS; Van Vliet M; Lindner U; Haider MA; Hlasny E; Spensieri P; Van Der Kwast TH; McCluskey SA; Kucharczyk W; Trachtenberg J AJR Am J Roentgenol; 2015 Aug; 205(2):W177-84. PubMed ID: 26204305 [TBL] [Abstract][Full Text] [Related]
48. Added Value of Multiparametric Ultrasonography in Magnetic Resonance Imaging and Ultrasonography Fusion-guided Biopsy of the Prostate in Patients With Suspicion for Prostate Cancer. Maxeiner A; Stephan C; Durmus T; Slowinski T; Cash H; Fischer T Urology; 2015 Jul; 86(1):108-14. PubMed ID: 26142593 [TBL] [Abstract][Full Text] [Related]
49. [FOCAL THERAPY WITH HIGH-INTENSITY FOCUSED ULTRASOUND FOR THE LOCALIZED PROSTATE CANCER BASED ON THE LOCALIZATION WITH MRI-TRUS FUSION IMAGE-GUIDED BIOPSY: 1-YEAR PROSPECTIVE STUDY]. Shoji S; Hiraiwa S; Ogawa T; Hanada I; Nakano M; Zakoji H; Hashida K; Matsumoto T; Hasebe T; Tajiri T; Uchida T; Miyajima A Nihon Hinyokika Gakkai Zasshi; 2018; 109(4):194-203. PubMed ID: 31631082 [TBL] [Abstract][Full Text] [Related]
50. Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes. Pfeiffer D; Berger J; Gross AJ BJU Int; 2012 Dec; 110(11):1702-7. PubMed ID: 22928703 [TBL] [Abstract][Full Text] [Related]
51. Central zone lesions on magnetic resonance imaging: Should we be concerned? Tan WP; Mazzone A; Shors S; Antoine N; Ekbal S; Khare N; McKiel C; Pessis D; Deane L Urol Oncol; 2017 Jan; 35(1):31.e7-31.e12. PubMed ID: 27692837 [TBL] [Abstract][Full Text] [Related]
52. MRI-guided Focused Ultrasound Focal Therapy for Intermediate-Risk Prostate Cancer: Final Results from a 2-year Phase II Clinical Trial. Ghai S; Finelli A; Corr K; Lajkosz K; McCluskey S; Chan R; Gertner M; van der Kwast TH; Incze PF; Zlotta AR; Kucharczyk W; Perlis N Radiology; 2024 Mar; 310(3):e231473. PubMed ID: 38441092 [TBL] [Abstract][Full Text] [Related]
53. Multiparametric MRI for Suspected Recurrent Prostate Cancer after HIFU:Is DCE still needed? Lotte R; Lafourcade A; Mozer P; Conort P; Barret E; Comperat E; Ezziane M; de Guibert PJ; Tavolaro S; Belin L; Boudghene F; Lucidarme O; Renard-Penna R Eur Radiol; 2018 Sep; 28(9):3760-3769. PubMed ID: 29633004 [TBL] [Abstract][Full Text] [Related]
54. Direct comparison of multiparametric magnetic resonance imaging (MRI) results with final histopathology in patients with proven prostate cancer in MRI/ultrasonography-fusion biopsy. Borkowetz A; Platzek I; Toma M; Renner T; Herout R; Baunacke M; Laniado M; Baretton G; Froehner M; Zastrow S; Wirth M BJU Int; 2016 Aug; 118(2):213-20. PubMed ID: 26935133 [TBL] [Abstract][Full Text] [Related]
55. Multiparametric Magnetic Resonance Imaging (MRI) and MRI-Transrectal Ultrasound Fusion Biopsy for Index Tumor Detection: Correlation with Radical Prostatectomy Specimen. Radtke JP; Schwab C; Wolf MB; Freitag MT; Alt CD; Kesch C; Popeneciu IV; Huettenbrink C; Gasch C; Klein T; Bonekamp D; Duensing S; Roth W; Schueler S; Stock C; Schlemmer HP; Roethke M; Hohenfellner M; Hadaschik BA Eur Urol; 2016 Nov; 70(5):846-853. PubMed ID: 26810346 [TBL] [Abstract][Full Text] [Related]
56. Focal Treatment for Unilateral Prostate Cancer Using High-Intensity Focal Ultrasound: A Comprehensive Study of Pooled Data. Albisinni S; Mélot C; Aoun F; Limani K; Peltier A; Rischmann P; van Velthoven R J Endourol; 2018 Sep; 32(9):797-804. PubMed ID: 29790383 [TBL] [Abstract][Full Text] [Related]
57. MRI/real-time ultrasound image fusion guided high-intensity focused ultrasound: a prospective comparative and functional analysis of different ablative techniques. DE Luca S; Checcucci E; Piramide F; Russo F; Alessio P; Garrou D; Peretti D; Sica M; Volpi G; Piana A; DE Cillis S; Amparore D; Manfredi M; Fiori C; Porpiglia F Minerva Urol Nephrol; 2023 Apr; 75(2):172-179. PubMed ID: 36286396 [TBL] [Abstract][Full Text] [Related]
58. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer. Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225 [TBL] [Abstract][Full Text] [Related]
59. Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer. Panebianco V; Valerio MC; Giuliani A; Pecoraro M; Ceravolo I; Barchetti G; Catalano C; Padhani AR Eur Urol Oncol; 2018 Aug; 1(3):208-214. PubMed ID: 31102623 [TBL] [Abstract][Full Text] [Related]
60. Accuracy of multiparametric magnetic resonance imaging to detect significant prostate cancer and index lesion location. Goldman H; Singh N; Harding C; McGirr J; Seal A; Duncan I; Sowter S ANZ J Surg; 2019 Jan; 89(1-2):106-110. PubMed ID: 30257273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]